Free. Unsubscribe any time.
Mural Oncology plc (MURA)
Mural Oncology plc filed 8 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 9 transactions and 49,675 shares. 8 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 2 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2025-11-10, came on the same day as the one before it (2025-11-10) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 7,148 shares, 2,112 more than the 5,036 in the filing before it.
- Of the 10 companies the register lists beside it in its industry, 5 have more plan statements on file than it and 5 have fewer.
- Its 8 filings on file run from 2025-02-25 to 2025-11-10, and state 4 plan adoption dates, from 2023-12-22 to 2024-10-24.
Trades in Mural Oncology plc 9
- Goodman Vicki L — 2025-02-24 · S · 13,186 shares
- Keson-Brookes Maiken — 2025-03-04 · S · 1,262 shares
- Loew Caroline — 2025-03-04 · S · 4,313 shares
- Keson-Brookes Maiken — 2025-03-05 · S · 1,469 shares
- Loew Caroline — 2025-07-07 · S · 12,531 shares
- Keson-Brookes Maiken — 2025-07-18 · S · 2,158 shares
- Keson-Brookes Maiken — 2025-07-22 · S · 2,572 shares
- Cutler Adam D. — 2025-11-03 · S · 7,148 shares
- Goodman Vicki L — 2025-11-10 · S · 5,036 shares
Adoption dates in Mural Oncology plc 4
- 2023-12-22 — stated in 4 filings
- 2024-03-27 — stated in 2 filings
- 2024-09-20 — stated in 1 filing
- 2024-10-24 — stated in 1 filing
Results prints in Mural Oncology plc 2
- 2025-03-11
- 2025-08-04
Trades before a print in Mural Oncology plc 0
- 6 days before the 2025-03-11 print — 2025-03-05 · S · Keson-Brookes Maiken · 1,469 shares
- 7 days before the 2025-03-11 print — 2025-03-04 · S · Keson-Brookes Maiken · 1,262 shares
- 7 days before the 2025-03-11 print — 2025-03-04 · S · Loew Caroline · 4,313 shares
- 13 days before the 2025-08-04 print — 2025-07-22 · S · Keson-Brookes Maiken · 2,572 shares
- 15 days before the 2025-03-11 print — 2025-02-24 · S · Goodman Vicki L · 13,186 shares
- 17 days before the 2025-08-04 print — 2025-07-18 · S · Keson-Brookes Maiken · 2,158 shares
- 28 days before the 2025-08-04 print — 2025-07-07 · S · Loew Caroline · 12,531 shares
Interval to Mural Oncology plc’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 3within 10 days
- 6shortest, days
- 2no later print
- Keson-Brookes Maiken 2025-03-04 · S · 7 days before the 2025-03-11 print · See Remarks
- Loew Caroline 2025-03-04 · S · 7 days before the 2025-03-11 print · Chief Executive Officer
- Keson-Brookes Maiken 2025-03-05 · S · 6 days before the 2025-03-11 print · See Remarks
Adoption dates Mural Oncology plc states
- 2023-12-22 in 4 filings
- 2024-03-27 in 2 filings
- 2024-09-20 in 1 filing
- 2024-10-24 in 1 filing
Filing text: “10b5-1 trading arrangement that was entered into by the Reporting Person on October 24, 2024”
Reported results dates on file
- 2025-03-11
- 2025-08-04
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.